Investment Rating - The report rates the electronic industry as "Outperform" compared to the market [1]. Core Insights - Neuralink is set to begin large-scale production of brain-computer interface (BCI) devices in 2026, transitioning to a more streamlined and nearly fully automated surgical process [2][5]. - The global BCI market is projected to reach $3.3 billion by 2026, with a compound annual growth rate (CAGR) of 12.7% from 2024 to 2026 [15][16]. - Non-invasive BCI technology is expected to dominate the market, accounting for over 80% of the BCI products by 2024 [16]. Summary by Sections Neuralink Development History - Neuralink was founded in 2016 by Elon Musk, focusing on invasive brain-computer interfaces and AI integration into the human cortex [6]. - The first product was launched in 2019, featuring ultra-thin flexible electrodes and a custom microchip [9]. Overview of Brain-Computer Interfaces - BCIs establish a direct communication pathway between the brain and external devices, aiming to interpret brain activity and convert it into commands for controlling devices [10]. Market Analysis - The global BCI market is expected to reach $2.6 billion in 2024, with a year-on-year growth of 8.3% [15]. - In China, the BCI market is projected to reach $460 million in 2024, growing by 18.5% [15]. Non-Invasive BCI Manufacturers - Companies like Kernel, Neurable, and MindMaze are actively developing non-invasive BCI technologies [20]. - Domestic companies such as Strong Brain Technology and Xiangyu Medical are also making significant advancements in this field [20].

Core Viewpoint - Qiangnao Technology, one of the "Six Little Dragons" in Hangzhou, has submitted a confidential IPO application for the Hong Kong stock market, following a strategic financing round of approximately 2 billion yuan, making it the second-largest single financing round in the global brain-computer interface sector, only behind Elon Musk's Neuralink [1] Group 1: Company Overview - Qiangnao Technology has focused on non-invasive brain-computer interface technology since its establishment in 2015 [1] - The company has developed a proprietary "super sensor" that captures weak brain electrical signals with high precision and converts them into control commands [1] - Qiangnao Technology has launched products such as smart bionic hands and brain-machine sleep instruments, with the smart bionic hand being the first non-invasive brain-computer interface device in China to receive FDA certification [1] Group 2: Financing History - The company completed its angel round and Pre-A round financing in 2016, followed by a $400 million A round financing in 2019 [1] - In 2025, Qiangnao Technology secured $30 million in Pre-B round financing and $20 million in B round financing from Daoshi Technology and 37 Interactive Entertainment [1]

Core Viewpoint - Qiangnao Technology, one of the "Six Little Dragons" in Hangzhou, has submitted a confidential IPO application for the Hong Kong stock market, following a significant strategic financing round of approximately 2 billion yuan [1] Group 1: Company Overview - Qiangnao Technology has focused on non-invasive brain-computer interface technology since its establishment in 2015 [1] - The company has developed a "super sensor" that captures weak brain electrical signals with high precision and converts them into control commands [1] - Qiangnao Technology has launched products such as smart bionic hands and brain-machine sleep instruments, with the smart bionic hand being the first non-invasive brain-computer interface device in China to receive FDA certification [1] Group 2: Financing and Investment - Recently, Qiangnao Technology completed a strategic financing round of about 2 billion yuan, attracting participation from several top international venture capital firms and industry capital in the consumer electronics sector [1] - This financing round is the second largest single round in the global brain-computer interface field, only behind Elon Musk's Neuralink [1] - The company has a history of financing, having completed angel and Pre-A rounds in 2016, a 400 million USD A round in 2019, and subsequent Pre-B and B rounds in 2025, raising 30 million USD and 20 million USD respectively [1]